ASML Holding (ASML.NL) declines in today's session, further extending yesterday's losses. A global leader in semiconductor equipment, is set to release its Q4 2024 earnings on January 29, 2025 before market open. This report comes at a critical time as the company faces both opportunities and headwinds, including the emergence of China’s AI disruptor DeepSeek and ongoing geopolitical challenges. Below is a concise summary of what investors should watch for.
Key Points
- Revenue & Earnings Projections
- Q4 Revenue: Estimated at €9.02 billion, a 26.6% year-on-year increase.
- Net Income: Forecasted at €2.62 billion, reflecting robust demand for lithography systems.
- Gross Margins: Expected at 49.6%, slightly lower due to High-NA EUV system costs.
- Earnings Per Share (EPS): Projected at €6.68.
- Order Bookings & Systems Sold
- Q4 bookings are estimated at €3.53 billion, with 121 lithography systems shipped.
- EUV orders remain subdued, with analysts anticipating a €1 billion contribution.
- DeepSeek’s Impact
- The rise of DeepSeek, a Chinese AI startup using less advanced, cost-efficient chips, could reshape demand for high-performance semiconductors.
- DeepSeek’s approach raises concerns about long-term EUV sales, a key driver for ASML.
- 2025 Guidance
- ASML maintains its 2025 revenue guidance at €30–35 billion, though expectations lean toward the lower end due to geopolitical uncertainties and customer delays.
- Geopolitical and Customer Risks
- Ongoing U.S. export restrictions limit ASML’s sales to China, its third-largest market.
- Dependency on major clients like TSMC, Samsung, and Intel makes the company sensitive to spending cutbacks.
Analyst Commentary
- Citi: Highlights a lower hurdle for ASML following its recent share price drop, with expectations for bookings as low as €2 billion.
- JPMorgan: Expects ASML to meet 2025 guidance unless Intel/Samsung make drastic cuts. Sees 2026 orders from TSMC in H1 2024.
- Barclays: Does not anticipate significant near-term recovery in EUV orders, given lingering uncertainties.
- ING: Optimistic about strong order momentum, despite limited surprises expected for the full-year update.
ASML’s Q4 results will be crucial in understanding its strategy to address evolving challenges:
- AI Demand & DeepSeek’s Impact: Will ASML address risks of cheaper AI models reducing reliance on cutting-edge chips?
- China Exposure: 15–20% of 2023 sales came from China; updates on export controls and domestic competition (e.g., SMEE’s lithography tools).
- 2025 Guidance Confidence: Any revisions to €30B–€35B sales target amid geopolitical and demand risks?
ASML’s monopoly in EUV lithography (critical for AI/advanced chips) and €6.17B cash cushion provide resilience. However, DeepSeek’s rise, China risks, and customer concentration (TSMC, Samsung, Intel) pose challenges. The earnings call’s tone on 2024 order visibility and AI-driven demand shifts will be pivotal for sentiment. Watch bookings data and management’s 2025 confidence – a beat on €4B+ orders or upbeat EUV commentary could catalyze a rebound.
Source: xStation 5
TSMC Earnings Preview: Will the Key Semiconductor Supplier Surprise the Market?
US Open: American Indices Rally on Anticipated End of Fed Balance Sheet Reduction
Bank of America, Wells Fargo, and Morgan Stanley: Q3 2025 Earnings Overview
Abbott reports no surprises in Q3, but tariff risks and lowered forecasts drag the share price down💡
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.